Cargando…
The pulmonary route as a way to drug repositioning in COVID-19 therapy
INTRODUCTION: The outbreak of the disease caused by the new coronavirus (COVID-19) has been affecting society's routine and its patterns of interaction worldwide, in addition to the impact on the global economy. To date, there is still no clinically effective treatment for this comorbidity, and...
Autores principales: | Sarcinelli, Michelle Alvares, Martins da Silva, Thalita, Artico Silva, Andressa Daniele, Ferreira de Carvalho Patricio, Beatriz, Mendes de Paiva, Flávia Costa, Santos de Lima, Raissa, Leal da Silva, Manuela, Antunes Rocha, Helvécio Vinícius |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903910/ https://www.ncbi.nlm.nih.gov/pubmed/33649708 http://dx.doi.org/10.1016/j.jddst.2021.102430 |
Ejemplares similares
-
Could the Lung Be a Gateway for Amphotericin B to Attack the Army of Fungi?
por: de Carvalho Patricio, Beatriz Ferreira, et al.
Publicado: (2022) -
In Vitro Release and In Vivo Pharmacokinetics of Praziquantel Loaded in Different Polymer Particles
por: Pereira, Emiliane Daher, et al.
Publicado: (2023) -
Influence of the Efavirenz Micronization on Tableting and Dissolution
por: Pinto, Eduardo Costa, et al.
Publicado: (2012) -
Use of Piranha Solution as An Alternative Route to Promote Bioactivation of PEEK Surface with Low Functionalization Times
por: dos Santos, Flavia Suzany Ferreira, et al.
Publicado: (2022) -
Essential Metabolic Routes as a Way to ESKAPE From Antibiotic Resistance
por: Barra, Angélica Luana C., et al.
Publicado: (2020)